Tyra Biosciences, Inc. (TYRA) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$48.87M*; Operating income -$49.00M; Depreciation and amortization $138.00K*.
- 2026-03-31: Basis Reported; EBITDA -$41.86M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$36.38M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$32.81M*; Operating income -$32.94M; Depreciation and amortization $131.00K*.
Complete source-backed ebitda history.
- Available history
- 2020-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$48.87M* | -$49.00M | $138.00K* | (m) | (m) | $66.00K* | -$31.08M* | (m) | $39.20M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$41.86M | (m) | (m) | (m) | (m) | $88.00K | -$32.57M | (m) | $33.47M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$36.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$32.81M* | -$32.94M | $131.00K* | (m) | (m) | $39.00K* | -$22.38M* | (m) | $25.47M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$31.31M* | -$31.45M | $140.00K* | (m) | (m) | $31.00K* | -$23.68M* | (m) | $24.31M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$31.71M | (m) | (m) | (m) | (m) | $14.00K | -$25.46M | (m) | $24.96M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$29.6M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$28.48M* | -$28.60M | $127.00K* | (m) | (m) | $52.00K* | -$17.90M* | (m) | $22.70M | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$23.41M* | -$23.53M | $126.00K* | (m) | (m) | $470.00K* | -$10.26M* | (m) | $18.00M | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$22.2M | (m) | (m) | (m) | (m) | $136.00K | -$22.03M | (m) | $17.20M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$25.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$23.88M* | -$23.96M | $83.00K* | (m) | (m) | $83.00K* | -$17.14M* | (m) | $19.27M | $0.00 | (m) |
|---|
| 2023-06-30 | Reported | -$15.93M* | -$16.01M | $89.00K* | (m) | (m) | $43.00K* | -$9.62M* | (m) | $12.16M | $0.00 | (m) |
|---|
| 2023-03-31 | Reported | -$14.25M | (m) | (m) | (m) | (m) | $41.00K | -$9.85M | (m) | $10.41M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$14.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$13.56M* | -$13.64M | $82.00K* | (m) | (m) | $48.00K* | -$12.21M* | (m) | $10.91M | $173.00K | (m) |
|---|
| 2022-06-30 | Reported | -$15.36M* | -$15.43M | $68.00K* | (m) | (m) | $251.00K* | -$17.17M* | (m) | $12.05M | $186.00K | (m) |
|---|
| 2022-03-31 | Reported | -$14.77M | (m) | (m) | (m) | (m) | $239.00K | -$8.93M | (m) | $9.64M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$9.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$6.60M* | -$6.64M | $41.00K* | (m) | (m) | $256.00K* | -$5.58M* | (m) | $5.48M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$5.48M* | -$5.51M | $27.00K* | (m) | (m) | $240.00K* | -$4.46M* | (m) | $4.38M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$4.19M | (m) | (m) | (m) | (m) | $60.00K | -$4.68M | (m) | $3.52M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$3.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$2.33M | (m) | (m) | (m) | (m) | (m) | (m) | $1.86M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$132.22M | (m) | (m) | (m) | (m) | $141.00K | -$95.14M | (m) | $102.93M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$103.66M | (m) | (m) | (m) | (m) | $664.00K | -$69.77M | (m) | $80.08M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$79.59M | (m) | (m) | (m) | (m) | $770.00K | -$50.14M | (m) | $62.52M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$58.63M | (m) | (m) | (m) | (m) | $559.00K | -$50.28M | (m) | $43.01M | (m) | $2.00K |
|---|
| 2021-12-31 | Reported | -$26.15M | (m) | (m) | (m) | (m) | $661.00K | -$23.75M | (m) | $20.64M | (m) | $1.00K |
|---|
| 2020-12-31 | Reported | -$9.25M | (m) | (m) | (m) | (m) | $312.00K | -$7.76M | (m) | $7.20M | (m) | $1.00K |
|---|